During the past decade, Forsyth Regional Cancer Center at Forsyth Medical Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 16 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Forsyth Regional Cancer Center at Forsyth Medical Center" #1 sponsor was "SWOG Cancer Research Network" with 9 trials, followed by "Alliance for Clinical Trials in Oncology" with 8 trials sponsored, "NSABP Foundation Inc" with 6 trials sponsored, "Radiation Therapy Oncology Group" with 6 trials sponsored and "Duke University" with 6 trials sponsored. Other sponsors include 3 different institutions and companies that sponsored additional 11 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Forsyth Regional Cancer Center at Forsyth Medical Center" #1 collaborator was "National Cancer Institute (NCI)" with 34 trials as a collaborator, "NRG Oncology" with 5 trials as a collaborator, "SWOG Cancer Research Network" with 4 trials as a collaborator, "NCIC Clinical Trials Group" with 3 trials as a collaborator and "Cancer and Leukemia Group B" with 2 trials as a collaborator. Other collaborators include 8 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "Forsyth Regional Cancer Center at Forsyth Medical Center" are "Breast Cancer" (12 trials), "Lung Cancer" (5 trials), "Prostate Cancer" (5 trials), "Metastatic Cancer" (3 trials) and "Acute Leukemia" (2 trials). Many other conditions were trialed in "Forsyth Regional Cancer Center at Forsyth Medical Center" in a lesser frequency.

Most popular intervention types in "Forsyth Regional Cancer Center at Forsyth Medical Center" are "Drug" (25 trials), "Radiation" (12 trials), "Biological" (8 trials), "Other" (7 trials) and "Procedure" (6 trials). Other intervention types were less common.

The name of intervention was led by "docetaxel" (7 trials), "radiation therapy" (6 trials), "cetuximab" (4 trials), "cisplatin" (4 trials) and "gemcitabine hydrochloride" (4 trials). Other intervention names were less common.

The vast majority of trials in "Forsyth Regional Cancer Center at Forsyth Medical Center" are 22 trials for "All" genders, 14 trials for "Female" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Forsyth Regional Cancer Center at Forsyth Medical Center". undefined are not yet recruiting, undefined are recruiting, 4 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 31 completed trials in Forsyth Regional Cancer Center at Forsyth Medical Center, undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Forsyth Regional Cancer Center at Forsyth Medical Center, 1 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 18 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 3 trials that are defined as “Not Applicable".